Value of postoperative radiotherapy for stage IIIa-N2 non-small cell lung cancer: an analysis based on SEER database.

Yang, Ran; Gong, Jun; Liao, Zhengkai; Yu, Jing; Zhang, Junhong; Xie, Conghua

Yang, Ran; Gong, Jun; Liao, Zhengkai; Yu, Jing; Zhang, Junhong; Xie, Conghua.

Afiliação

Yang R; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Gong J; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Liao Z; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yu J; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhang J; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xie C; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Transl Cancer Res ; 11(7): 2194-2204, 2022 Jul.

Article em En | MEDLINE | ID: mdl-35966291

Palavras-chave

Non-small cell lung cancer (NSCLC); Surveillance, Epidemiology and End Results (SEER) database; postoperative radiotherapy (PORT); survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article